Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Clin Exp Dermatol ; 2024 May 13.
Artigo em Inglês | MEDLINE | ID: mdl-38738492

RESUMO

BACKGROUND: ChatGPT® (OpenAI; California, USA) is an open-access chatbot developed using artificial intelligence (AI) that generates human-like responses. OBJECTIVE: To evaluate the ChatGPT-4's concordance with three dermatologic surgeons on reconstructions for dermatological surgical defects. METHODS: A total of 70 cases of non-melanoma skin cancer treated with surgery were obtained from clinical records for analysis. A list of 30 reconstruction options was designed by the main authors which included primary closure, secondary skin closure, skin flaps and skin grafts. Three blinded dermatologic surgeons, along with ChatGPT-4, were asked to select two reconstruction options from the list. RESULTS: Seventy responses were analyzed using Cohen's kappa looking for concordance between each dermatologist and ChatGPT. The level of agreement among dermatologic surgeons was higher compared to that between dermatologic surgeons and ChatGPT, highlighting differences in decision-making. In the best reconstruction technique, the results indicated a fair level of agreement among the dermatologists ranging between κ 0.268 and 0.331. However, the concordance with ChatGPT-4 and the dermatologists was slight with κ values from 0.107 to 0.121. In the analysis of the second-choice options, the dermatologists showed slight agreement. In contrast, the level of concordance between ChatGPT-4 and the dermatologists was below chance. CONCLUSIONS: As anticipated, this study reveals variability in medical decisions between dermatologic surgeons and ChatGPT. Although these tools offer exciting possibilities for the future, it's vital to acknowledge the risk of inadvertently rely on non-certified AI for medical advice.

2.
Clin Exp Dermatol ; 47(6): 1180-1181, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35042274

RESUMO

Dermoscopy of mycetoma has white structures as the predominant feature, while white scale and yellowish structures were also consistent in our findings with available literature.


Assuntos
Dermoscopia , Micetoma , Humanos , Micetoma/diagnóstico por imagem , Pesquisa
4.
Exp Dermatol ; 29(3): 259-264, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31997403

RESUMO

Alopecia areata (AA) is an autoimmune disease of the hair follicle. Keratinocytes of the hair follicle generate an immunosuppressive environment by the local secretion of hormones of the hypothalamic-pituitary-adrenal axis of the skin (skin HPA analog). Our objective was to measure the local production of corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and α-melanocyte-stimulating hormone (α-MSH) in the scalp tissue of patients with AA before and after ultraviolet A1 (UVA-1) phototherapy to determine their role in the pathogenesis of AA and the effect of UVA-1 on the AA hormonal environment. This was a retrospective and descriptive study of skin samples from 22 patients with AA before and after UVA-1 treatment. We compared the changes in the local hormonal environment by measuring CRH, ACTH, type 2 melanocortin receptor (ACTH receptor) and α-MSH with immunohistochemical stains. The positivity of MSH was significantly higher (P = .037) in the post-treatment samples compared with the baseline value. ACTH was significantly higher in intensity (P = .032) in the post-treatment samples compared with the initial value. CRH was significantly higher in intensity (P = .013) in baseline samples compared with the final biopsies. The positivity of the ACTH receptor MC2R was not different between the two groups (P = .626). In AA, an interruption in the signalling of CRH could decrease the local concentration of ACTH and MSH, and consequently, the immunosuppressive effect of these hormones. This phenomenon is normalized in the skin treated with UVA-1. A defective signalling system in the cutaneous HPA axis may be involved in the pathogenesis of AA.


Assuntos
Alopecia em Áreas/radioterapia , Hormônios/metabolismo , Fototerapia/métodos , Couro Cabeludo/metabolismo , Raios Ultravioleta , alfa-MSH/metabolismo , Hormônio Adrenocorticotrópico/metabolismo , Adulto , Alopecia em Áreas/metabolismo , Biópsia , Hormônio Liberador da Corticotropina/metabolismo , Folículo Piloso/metabolismo , Humanos , Sistema Hipotálamo-Hipofisário/patologia , Imuno-Histoquímica , Pessoa de Meia-Idade , Sistema Hipófise-Suprarrenal/metabolismo , Receptor Tipo 2 de Melanocortina/metabolismo , Estudos Retrospectivos , Transdução de Sinais , Pele/metabolismo
6.
Photodermatol Photoimmunol Photomed ; 35(5): 378-380, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31062884

RESUMO

Lichen sclerosus (LS) is an uncommon, chronic, lymphocyte-mediated, inflammatory dermatosis characterized by ivory-white patches with scar-like atrophy. Extragenital bullous lichen sclerosus may rarely affect palms and soles, causing severe pain and substantially impairing quality of life. We present the first case of acral bullous lichen sclerosus intolerant to UVA-1 phototherapy successfully treated with low doses of narrowband ultraviolet B phototherapy.


Assuntos
Líquen Escleroso e Atrófico , Dor , Qualidade de Vida , Raios Ultravioleta/efeitos adversos , Terapia Ultravioleta , Feminino , Humanos , Líquen Escleroso e Atrófico/patologia , Líquen Escleroso e Atrófico/radioterapia , Pessoa de Meia-Idade , Dor/patologia , Dor/radioterapia
9.
J Drugs Dermatol ; 17(10): 1123-1125, 2018 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-30365594

RESUMO

Bullous morphea is rare clinical variant of localized scleroderma characterized by the formation of bullae on sclerotic morphea plaques. Severe disease may be highly disabling and greatly impair quality of life. Current treatment strategies are based on anecdotal reports of clinical experience and include topical corticosteroids, methotrexate and phototherapy. Herein, we describe the case of a 56-year-old woman with progressive bullous sclerotic lesions who was successfully treated with mycophenolate mofetil after treatment failure with psoralen plus ultraviolet A therapy, ultraviolet A1 phototherapy, and methotrexate. Treatment with mycophenolate mofetil halted disease progression after 8 weeks. No major adverse effects were recorded in a 3-year follow-up with continuous treatment. This case suggests mycophenolate mofetil may be considered as an alternative for the treatment of resistant bullous morphea lesions. J Drugs Dermatol. 2018;17(10):1123-1125.


Assuntos
Fármacos Dermatológicos/uso terapêutico , Ácido Micofenólico/uso terapêutico , Esclerodermia Localizada/tratamento farmacológico , Fármacos Dermatológicos/administração & dosagem , Feminino , Humanos , Metotrexato/uso terapêutico , Pessoa de Meia-Idade , Ácido Micofenólico/administração & dosagem , Fitoterapia , Qualidade de Vida , Esclerodermia Localizada/patologia , Esclerodermia Localizada/psicologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA